Abstract
The peptide receptor radionuclide therapy (PRRT) 177Lu-DOTATATE binds to somatostatin receptors ([1][1]). A multidisciplinary team should be involved when treating patients with 177Lu-DOTATATE PRRT, including medical oncologists, nuclear medicine physicians and technologists, nurses, radiation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
